BP344

甲氧苄啶

British Pharmacopoeia (BP) Reference Standard

• 别名: 2,4-二氨基-5-(3,4,5-三甲氧基苄基)嘧啶, NSC 106568
• 经验公式（希尔记法）: C₁₄H₁₈N₄O₃
• CAS号: 738-70-5
• 分子量: 290.32
• Beilstein: 625127
• EC 号: 212-006-2
• MDL编号: MFCD00036761
• UNSPSC代码: 41116107
• NACRES: NA.24

属性

• 等级: pharmaceutical primary standard
• API类: trimethoprim
• 表单: powder
• 保质期: limited shelf life, expiry date on the label
• 制造商/商品名称: BP
• 应用: pharmaceutical; pharmaceutical small molecule
• 包装形式: neat
• 储存温度: 2-8°C
• SMILES字符串: COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC
• InChI: 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)
• InChI key: IEDVJHCEMCRBQM-UHFFFAOYSA-N

说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

应用

主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。

Trimethoprim BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Paediatric Co-trimoxazole Oral Suspension

Co-trimazine Veterinary Oral Powder

Co-trimazine Tablets

Co-trimoxazole Dispersible Tablets

Co-trimoxazole Infusion

Co-trimazine Injection

Co-trimoxazole Tablets

Co-trimoxazole Oral Suspension

Trimethoprim Oral Suspension

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他说明

Sales restrictions may apply.

安全信息

• 象形图: GHS08,GHS07
• 警示用语：: Warning
• 危险声明: H302,H361d
• 预防措施声明: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405
• 危险分类: Acute Tox. 4 Oral - Repr. 2
• 储存分类代码: 11 - Combustible Solids
• WGK: WGK 3
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable